An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma.
Francesca ReggianiElisabetta SautaFederica TorricelliEleonora ZanettiElena TagliaviniGiacomo SantandreaGiulia GobbiGiovanna DamiaRiccardo BellazziDavide AmbrosettiAlessia CiarrocchiValentina SancisiPublished in: Molecular cancer (2021)
Keyphrases